G. Leonard Baker Jr. is Director at CORCEPT THERAPEUTICS INC (CORT). They have made 73 open-market trades across 6 companies since 2006, most recently 2026-03-17.
CIK 0001201715
62 open-market purchases totalling $40.6M since 2006, against 11 sales. Across 37 scored buys the stock is up 9.7% at ninety days, and 7.6 points ahead of the S&P over the same stretch.
37 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 46% | 62% | 49% |
| Avg Move | -4.1% | +7.2% | +9.7% |
| Alpha | -1.1% | +6.6% | +7.6% |
| Scored | 37 | 37 | 37 |
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 100% | 80% | 80% |
| Avg Move | -24.9% | -3.0% | -3.0% |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CORT | BUY | 2026-03-17 | 2026-03-19 | $33.14 | $6.6M | +13.5% | +30.5% | +130.0% |
| CORT | BUY | 2021-06-11 | 2021-06-15 | $21.53 | $3.2M | -0.1% | -10.6% | -8.4% |
| CORT | BUY | 2020-11-30 | 2020-12-02 | $22.79 | $27K | +11.3% | +13.2% | +7.5% |
| CORT | BUY | 2020-11-25 | 2020-11-30 | $22.81 | $8K | +9.6% | +13.8% | +10.7% |
| CORT | BUY | 2020-11-23 | 2020-11-24 | $22.93 | $68K | +3.7% | +18.9% | +16.9% |
| CORT | BUY | 2020-11-18 | 2020-11-19 | $17.91 | $42K | -0.9% | +15.2% | +20.1% |
| CORT | BUY | 2020-11-13 | 2020-11-17 | $17.82 | $285K | +24.1% | +47.1% | +54.0% |
| CORT | BUY | 2020-11-09 | 2020-11-12 | $17.79 | $402K | +21.9% | +36.7% | +58.6% |
| CORT | BUY | 2020-11-06 | 2020-11-10 | $17.98 | $243K | +25.8% | +32.5% | +60.7% |
| CORT | BUY | 2020-08-28 | 2020-09-01 | $12.49 | $1.2M | +38.8% | +34.0% | +74.6% |
| CORT | SELL | 2020-05-28 | 2020-05-29 | $15.70 | $471K | +2.5% | +11.7% | -16.9% |
| CORT | SELL | 2019-06-03 | 2019-06-05 | $9.78 | $293K | +2.4% | +7.3% | +20.7% |
| CORT | BUY | 2019-02-12 | 2019-02-14 | $11.39 | $1.1M | +9.3% | +6.7% | -5.2% |
| CORT | BUY | 2018-11-21 | 2018-11-26 | $12.73 | $1.3M | -2.6% | -3.1% | -14.2% |
| CORT | BUY | 2018-11-09 | 2018-11-14 | $12.94 | $4.4M | +8.5% | +28.3% | -7.4% |
| CORT | BUY | 2018-08-20 | 2018-08-22 | $12.92 | $922K | +8.6% | +3.9% | -11.3% |
| CORT | BUY | 2018-08-16 | 2018-08-20 | $12.52 | $1.4M | +13.1% | +7.2% | -8.8% |
| CORT | BUY | 2018-08-14 | 2018-08-16 | $12.48 | $3.2M | +7.3% | +14.7% | -3.2% |
| CORT | SELL | 2018-05-11 | 2018-05-15 | $16.01 | $961K | +5.8% | +9.4% | -30.6% |
| CORT | SELL | 2017-11-13 | 2017-11-15 | $17.59 | $528K | -5.1% | -13.1% | -21.9% |
| CORT | BUY | 2016-05-06 | 2016-05-10 | $4.88 | $616K | +6.4% | +8.7% | +15.9% |
| CORT | SELL | 2015-03-20 | 2015-03-24 | $5.85 | $1.8M | -27.4% | -3.9% | -3.9% |
| THLD | SELL | 2014-10-01 | 2014-10-03 | $3.77 | $893K | -25.5% | -4.0% | -4.0% |
| THLD | SELL | 2014-06-20 | 2014-06-23 | $4.01 | $56K | -25.5% | -4.0% | -4.0% |
| MATR | SELL | 2014-06-12 | 2014-06-16 | $5.12 | $106K | -20.8% | +0.8% | +0.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Scored | 5 | 5 | 5 |